CLAUDIA CHARRY: Open Payments
NPI 1992335038 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 10 payments from 6 companies in 2025. Trend: 2023 $986 · 2024 $237 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $66 |
| Surgical Specialties Corporation (us), Inc. (dba Corza Medical) | 1 | $39 |
| Actelion Pharmaceuticals US, Inc. | 2 | $34 |
| United Therapeutics Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $17 |
Products named: NUCALA, UPTRAVI, Tyvaso, ZEPBOUND, LUMRYZ.
Industry payments across NJ — which companies pay providers there.
